Výsledky vyhledávání - "Ouedraogo, P. E."

Maternal HIV-1 disease progression 18-24 months postdelivery according to antiretroviral prophylaxis regimen (triple-antiretroviral prophylaxis during pregnancy and breastfeeding vs Zidovudine/single-dose Nevirapine prophylaxis) : the Kesho Bora randomized controlled trial

Autor: Fao, P., Ky-Zerbo, O., Gouem, C., Somda, P., Hien, H., Ouedraogo, P. E., Kania, D., Sanou, A., Kossiwavi, I. A., Sanogo, B., Ouedraogo, M., Siribie, I., Valea, D., Ouedraogo, S., Some, R., Rouet, F., Rollins, N., McFetridge, L., Naidu, K., Luchters, S., Reyners, M., Irungu, E., Katingima, C., Mwaura, M., Ouattara, G., Mandaliya, K., Wambua, S., Thiongo, M., Nduati, R., Kose, J., Njagi, E., Mwaura, P., Newell, M. L., Mepham, S., Viljoen, J., Bland, R., Mthethwa, L., Bazin, B., Rekacewicz, C., Taylor, A., Flowers, N., Thigpen, M., Fowler, M. G., Jamieson, D., Mofenson, L. M., Read, J. S., Bork, Kirsten, Cames, Cécile, Cournil, Amandine, Claeys, P., Temmerman, M., Van de Perre, P., Becquart, Pierre, Foulongne, V., Segondy, M., de Vincenzi, I., Gaillard, P., Farley, T., Habib, N., Landoulsi, S.

Background. Antiretroviral (ARV) prophylaxis effectively reduces mother-to-child transmission of human immunodeficiency virus type 1 (HIV). However, it is unclear whether stopping ARVs after breastfeeding cessation affects maternal HIV disease progre

Vyhledávací nástroje:

Upřesnit hledání